FIRMQUARRYResearch workspace

US_FEDERAL process · buyer country US · award

PRIME VENDOR PHARMCEUTICAL CONTRACT INTRAGENCY AGREEMENT 943 CONTRACT # 36W79720D001 MCKESSON-MAT OCT 1, 2026 - SEP 30, 2027

Department of Justice

Procedure CONT_AWD_15B11727F00000002_1540_36W79720D0001_3600CPV 325412Biotechnology & Pharmaceuticals
Not reported
Data last updated Oct 22, 2026 · Source: USAspending.gov
Buyer identifier
Not reported
Primary supplier
MCKESSON CORPORATION
Procurement method
Not reported
Tender deadline
Not reported
Contract period
Not reported — Not reported
Native value
Not reported
USD comparison
Not shown — no auditable FX observation
Official source
Open notice ↗

Description

PRIME VENDOR PHARMCEUTICAL CONTRACT INTRAGENCY AGREEMENT 943 CONTRACT # 36W79720D001 MCKESSON-MAT OCT 1, 2026 - SEP 30, 2027

Suppliers

Official lifecycle

Process timeline

  1. Award announced

    PRIME VENDOR PHARMCEUTICAL CONTRACT INTRAGENCY AGREEMENT 943 CONTRACT # 36W79720D001 MCKESSON-MAT OCT 1, 2026 - SEP 30, 2027

    US · usaspendingSource ↗
  2. Value increased

    PRIME VENDOR PHARMCEUTICAL CONTRACT INTRAGENCY AGREEMENT 943 CONTRACT # 36W79720D001 MCKESSON-MAT OCT 1, 2026 - SEP 30, 2027

    US · usaspending$30KSource ↗

Auditable model output

Predictive intelligence

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Append-only source history

Source records

RecordDateStagesFetched